<DOC>
	<DOCNO>NCT00353561</DOCNO>
	<brief_summary>Clinical mycological response oral fluconazole boric acid suppository assess patient diabetes mellitus vulvovaginal candidiasis .</brief_summary>
	<brief_title>Diabetes Mellitus Vulvovaginal Candidiasis</brief_title>
	<detailed_description>A high proportion vulvovaginal candidiasis due C.glabrata respond poorly fluconazole therapy . We assess clinical relief mycological cure response oral fluconazole boric acid suppository patient diabetes mellitus vulvovaginal candidiasis give Randomized trial . Fluconazole give standard oral single dose ( 150 mg ) fluconazole boric acid vaginal suppository give dose 600 mg/daily 14 uninterrupted day .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Consecutive patient diabetes mellitus attend Endocrine OPD All India Institute Medical Sciences diagnosis vulvovaginal candidiasis base presence clinical sign symptom growth Candida species culture high vaginal swab ( HVS ) . Patients vaginal discharge Candida growth detect fungal culture exclude . Subjects also exclude pregnancy , Sexually inactive girl , Age &gt; 65 year , renal failure steroid therapy . Patients give consent pelvic examination , Those treat kind vaginal discharge past three month comply boric acid therapy report 15th day repeat examination exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>